- Home
- REPL vs HBT Comparison
REPL vs HBT Comparison
Compare REPL & HBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- HBT
- Stock Information
- Founded
- REPL 2015
- HBT 1920
- Country
- REPL United States
- HBT United States
- Employees
- REPL N/A
- HBT N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- HBT Major Banks
- Sector
- REPL Health Care
- HBT Finance
- Exchange
- REPL Nasdaq
- HBT Nasdaq
- Market Cap
- REPL 578.4M
- HBT 693.0M
- IPO Year
- REPL 2018
- HBT 2019
- Fundamental
- Price
- REPL $8.00
- HBT $21.99
- Analyst Decision
- REPL Strong Buy
- HBT Hold
- Analyst Count
- REPL 6
- HBT 5
- Target Price
- REPL $20.00
- HBT $24.80
- AVG Volume (30 Days)
- REPL 967.9K
- HBT 44.6K
- Earning Date
- REPL 05-15-2025
- HBT 04-21-2025
- Dividend Yield
- REPL N/A
- HBT 3.82%
- EPS Growth
- REPL N/A
- HBT 9.18
- EPS
- REPL N/A
- HBT 2.26
- Revenue
- REPL N/A
- HBT $221,390,000.00
- Revenue This Year
- REPL $31.16
- HBT $7.01
- Revenue Next Year
- REPL N/A
- HBT $2.71
- P/E Ratio
- REPL N/A
- HBT $9.73
- Revenue Growth
- REPL N/A
- HBT N/A
- 52 Week Low
- REPL $4.92
- HBT $18.01
- 52 Week High
- REPL $17.00
- HBT $26.25
- Technical
- Relative Strength Index (RSI)
- REPL 36.82
- HBT 46.15
- Support Level
- REPL $6.44
- HBT $21.29
- Resistance Level
- REPL $7.97
- HBT $22.31
- Average True Range (ATR)
- REPL 0.73
- HBT 0.97
- MACD
- REPL 0.08
- HBT 0.09
- Stochastic Oscillator
- REPL 41.47
- HBT 75.98
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About HBT HBT Financial Inc.
HBT Financial Inc provides a comprehensive suite of business, commercial, wealth management, and retail banking products and services to individuals, businesses, and municipal entities throughout Central and Northeastern Illinois and Eastern Iowa. It operates through one reportable segment: community banking.